I had actually forgotten that $ANP also has positive phase 2 results for multiple sclerosis (immune disease after all). And also for acromegaly. Not just duschennes muscular dystrophy - their main game.
They must concentrate resources on Duschennes, but I'd be surprised if not also advancing other indications and/ or seeking partnerships.
Speaking of partnerships, given Seraptas failure for their gene therapy, id be surprised if they aren't talking to $ANP regarding partnership
I'd expect trial protocol to be ready soon and presented to European regulator for approval. This next phs2b trial likely be the final regulatory trial. Serapta is valued at $6b even without gene therapy. How much could $ANP be worth. Even if trial is had as good as previous one
You can follow @jezzyASX.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:
Those who think consciousness raising & movement building are disconnected, or even a distraction from electoral politics have not paid attention to the history of social change.In this thread, we
Read more
The 2020s will be known as the Remote Work decadeA few predictions of what is likely to emerge[ a thread ] Third Space: Office and Working from Home will
Read more
1/29: Have you ever had a concept explained to you that helps frame complex issues you’ve been wrestling with and opens your eyes to new possibilities? A concept that I
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.